NASDAQ:PETS - Petmed Express Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$22.84 +0.16 (+0.71 %)
(As of 12/17/2018 12:56 PM ET)
Previous Close$22.68
Today's Range$22.67 - $23.44
52-Week Range$22.06 - $57.80
Volume22,435 shs
Average Volume566,428 shs
Market Capitalization$468.89 million
P/E Ratio10.90
Dividend Yield4.76%
Beta0.8
PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes. It also sells food, beds, crates, stairs, strollers, and other pet supplies. The company sells its products through its Internet Website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
Current SymbolNASDAQ:PETS
Previous Symbol
CUSIP71638210
Phone561-526-4444

Debt

Debt-to-Equity RatioN/A
Current Ratio6.99
Quick Ratio5.31

Price-To-Earnings

Trailing P/E Ratio10.90
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$273.80 million
Price / Sales1.72
Cash Flow$1.9258 per share
Price / Cash Flow11.86
Book Value$5.62 per share
Price / Book4.06

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$37.28 million
Net Margins14.88%
Return on Equity35.53%
Return on Assets29.82%

Miscellaneous

Employees187
Outstanding Shares20,670,000
Market Cap$468.89 million
OptionableOptionable

Petmed Express (NASDAQ:PETS) Frequently Asked Questions

What is Petmed Express' stock symbol?

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?

Petmed Express announced a quarterly dividend on Tuesday, October 23rd. Stockholders of record on Monday, November 5th will be paid a dividend of $0.27 per share on Friday, November 16th. This represents a $1.08 annualized dividend and a dividend yield of 4.70%. The ex-dividend date of this dividend is Friday, November 2nd. View Petmed Express' Dividend History.

How were Petmed Express' earnings last quarter?

Petmed Express Inc (NASDAQ:PETS) announced its quarterly earnings results on Monday, October, 22nd. The company reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.50 by $0.02. The business had revenue of $71.40 million for the quarter, compared to the consensus estimate of $71.93 million. Petmed Express had a net margin of 14.88% and a return on equity of 35.53%. The firm's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.43 EPS. View Petmed Express' Earnings History.

When is Petmed Express' next earnings date?

Petmed Express is scheduled to release their next quarterly earnings announcement on Monday, January 28th 2019. View Earnings Estimates for Petmed Express.

What price target have analysts set for PETS?

3 equities research analysts have issued 12 month target prices for Petmed Express' shares. Their predictions range from $32.00 to $58.00. On average, they anticipate Petmed Express' share price to reach $45.00 in the next twelve months. This suggests a possible upside of 95.7% from the stock's current price. View Analyst Price Targets for Petmed Express.

What is the consensus analysts' recommendation for Petmed Express?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Petmed Express.

Has Petmed Express been receiving favorable news coverage?

Media stories about PETS stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Petmed Express earned a news impact score of 1.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term.

Who are some of Petmed Express' key competitors?

Who are Petmed Express' key executives?

Petmed Express' management team includes the folowing people:
  • Mr. Menderes Akdag, CEO, Pres & Director (Age 57)
  • Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 49)
  • Ms. Alison Berges, Corp. Sec. & Gen. Counsel

Who are Petmed Express' major shareholders?

Petmed Express' stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.72%), Vanguard Group Inc (9.69%), Vanguard Group Inc. (9.69%), Renaissance Technologies LLC (8.46%), Epoch Investment Partners Inc. (4.15%) and Penserra Capital Management LLC (2.35%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for Petmed Express.

Which institutional investors are selling Petmed Express stock?

PETS stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Vanguard Group Inc, Teachers Advisors LLC, Prudential Financial Inc., Credit Suisse AG, Allianz Asset Management GmbH, First Trust Advisors LP and Copeland Capital Management LLC. Company insiders that have sold Petmed Express company stock in the last year include Frank J Formica, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Insider Buying and Selling for Petmed Express.

Which institutional investors are buying Petmed Express stock?

PETS stock was acquired by a variety of institutional investors in the last quarter, including Epoch Investment Partners Inc., Morgan Stanley, BlackRock Inc., New Amsterdam Partners LLC NY, Menlo Advisors LLC, Renaissance Technologies LLC, Point72 Asset Management L.P. and Penserra Capital Management LLC. View Insider Buying and Selling for Petmed Express.

How do I buy shares of Petmed Express?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Petmed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $23.00.

How big of a company is Petmed Express?

Petmed Express has a market capitalization of $468.89 million and generates $273.80 million in revenue each year. Petmed Express employs 187 workers across the globe.

What is Petmed Express' official website?

The official website for Petmed Express is http://www.1800petmeds.com.

How can I contact Petmed Express?

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.


MarketBeat Community Rating for Petmed Express (NASDAQ PETS)

Community Ranking:  1.4 out of 5 (star)
Outperform Votes:  135 (Vote Outperform)
Underperform Votes:  337 (Vote Underperform)
Total Votes:  472
MarketBeat's community ratings are surveys of what our community members think about Petmed Express and other stocks. Vote "Outperform" if you believe PETS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel